SMAD1 and hepatocellular carcinoma: Together, these results indicate that BMP9 can inhibit the Rho‐ROCK‐MLC pathway by p‐Smad1/5/8‐Smad6‐p‐Smad3 signalling in HBV‐infected HCC.